UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

JNCI : Journal of the National Cancer Institute, 2018-01, Vol.110 (1), p.14-30

2018

Volltextzugriff (PDF)

Feature selection methodology for longitudinal cone-beam CT radiomics

Acta oncologica, 2017-11, Vol.56 (11), p.1537-1543

2017

Volltextzugriff (PDF)

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making

Radiotherapy and oncology, 2014-07, Vol.112 (1), p.37-43

2014

Volltextzugriff (PDF)

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.6-11

2018

Volltextzugriff (PDF)

Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review

Radiotherapy and oncology, 2012-11, Vol.105 (2), p.145-149

2012

Volltextzugriff (PDF)

Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making

Health expectations : an international journal of public participation in health care and health policy, 2022-08, Vol.25 (4), p.1342-1351

2022

Volltextzugriff (PDF)

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

Clinical and translational radiation oncology, 2020-03, Vol.21, p.49-55

2020

Volltextzugriff (PDF)

Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.1319-1324

2013

Volltextzugriff (PDF)

State of the Art Radiation Therapy for Lung Cancer 2012: A Glimpse of the Future

Clinical lung cancer, 2013-03, Vol.14 (2), p.89-95

2013

Volltextzugriff (PDF)

Automatic selection of lung cancer patients for adaptive radiotherapy using cone-beam CT imaging

Physics and imaging in radiation oncology, 2017-01, Vol.1, p.21-27

2017

Volltextzugriff (PDF)

Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy

Practical Radiation Oncology, 2015-05, Vol.5 (3), p.e135-e141

2015

Volltextzugriff (PDF)

Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images

Radiotherapy and oncology, 2017-06, Vol.123 (3), p.363-369

2017

Volltextzugriff (PDF)

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

Autophagy, 2021-09, Vol.17 (9), p.2604-2612

2021

Volltextzugriff (PDF)

Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

Journal of thoracic oncology, 2012-10, Vol.7 (10), p.1547-1555

2012

Volltextzugriff (PDF)

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1958-1961

2018

Volltextzugriff (PDF)

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

Radiotherapy and oncology, 2019-02, Vol.131, p.166-173

2019

Volltextzugriff (PDF)

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

Radiotherapy and oncology, 2019-07, Vol.136, p.78-85

2019

Volltextzugriff (PDF)

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test

Medical physics (Lancaster), 2018-11, Vol.45 (11), p.5105-5115

2018

Volltextzugriff (PDF)

18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial

Radiotherapy and oncology, 2023-04, Vol.181, p.109492, Article 109492

2023

Volltextzugriff (PDF)

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

Lung cancer (Amsterdam, Netherlands), 2017-06, Vol.108, p.150-153

2017

Volltextzugriff (PDF)

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Radiotherapy and oncology, 2019-06, Vol.135, p.141-146

2019

Volltextzugriff (PDF)

Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial

Radiotherapy and oncology, 2024-07, Vol.196, p.110312, Article 110312

2024

Volltextzugriff (PDF)

Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.642-650

2018

Volltextzugriff (PDF)

‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy

Radiotherapy and oncology, 2013-10, Vol.109 (1), p.159-164

2013

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Oncology
(41)
Humans
(36)
Radiology, Nuclear Medicine & Medical Imaging
(25)
Female
(24)
Male
(23)
Aged
(22)
Middle Aged
(19)
Neoplasm Staging
(18)
Hematology, Oncology And Palliative Medicine
(17)
Lung Neoplasms - Pathology
(16)
Adult
(14)
Carcinoma, Non-Small-Cell Lung - Radiotherapy
(14)
Lung Neoplasms - Radiotherapy
(14)
Radiotherapy
(14)
Lung Neoplasms - Diagnostic Imaging
(13)
Aged, 80 And Over
(12)
Carcinoma, Non-Small-Cell Lung - Diagnostic Imaging
(12)
Carcinoma, Non-Small-Cell Lung - Pathology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

Feature selection methodology for longitudinal cone-beam CT radiomics

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review

Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer

State of the Art Radiation Therapy for Lung Cancer 2012: A Glimpse of the Future

Automatic selection of lung cancer patients for adaptive radiotherapy using cone-beam CT imaging

Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy

Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial

Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test

18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial

Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume

‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy

Suchergebnisse filtern